Ariad Pharmaceuticals, Inc. Share Price
Equities
US04033A1007
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2017 | Takeda Pharmaceutical : Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal | RE |
2014 | Dai ichi Life Insurance : U.S. futures flat with Dow, S&P at record levels | RE |
Managers | Title | Age | Since |
---|---|---|---|
Teresa Bitetti
PSD | President | - | - |
Tetsu Inada
BRD | Director/Board Member | - | - |
Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Teresa Bitetti
PSD | President | - | - |
Tetsu Inada
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-1.10% | 104B | |
+6.95% | 97.47B | |
+5.71% | 22.25B | |
-13.06% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.50% | 16.36B | |
+8.19% | 14.39B | |
+39.70% | 12.37B |
- Stock Market
- Equities
- Stock